165 related articles for article (PubMed ID: 16365741)
1. HLA class I and class II frequencies in patients with cutaneous malignant melanoma from southeastern Spain: the role of HLA-C in disease prognosis.
Campillo JA; Martínez-Escribano JA; Muro M; Moya-Quiles R; Marín LA; Montes-Ares O; Guerra N; Sánchez-Pedreño P; Frías JF; Lozano JA; García-Alonso AM; Alvarez-López MR
Immunogenetics; 2006 Jan; 57(12):926-33. PubMed ID: 16365741
[TBL] [Abstract][Full Text] [Related]
2. HLA class II polymorphisms in Spanish melanoma patients: homozygosity for HLA-DQA1 locus can be a potential melanoma risk factor.
Planelles D; Nagore E; Moret A; Botella-Estrada R; Vila E; Guillén C; Montoro JA
Br J Dermatol; 2006 Feb; 154(2):261-6. PubMed ID: 16433795
[TBL] [Abstract][Full Text] [Related]
3. HLA allele frequency and clinical outcome in Italian patients with cutaneous melanoma.
Luongo V; Pirozzi G; Caracò C; Errico S; de Angelis F; Celentano E; Paino F; Chiofalo MG; Luongo M; Mozzillo N; Lombardi ML
Tissue Antigens; 2004 Jul; 64(1):84-7. PubMed ID: 15191529
[TBL] [Abstract][Full Text] [Related]
4. KIR gene variability in cutaneous malignant melanoma: influence of KIR2D/HLA-C pairings on disease susceptibility and prognosis.
Campillo JA; Legaz I; López-Álvarez MR; Bolarín JM; Las Heras B; Muro M; Minguela A; Moya-Quiles MR; Blanco-García R; Martínez-Banaclocha H; García-Alonso AM; Alvarez-López MR; Martínez-Escribano JA
Immunogenetics; 2013 May; 65(5):333-43. PubMed ID: 23370861
[TBL] [Abstract][Full Text] [Related]
5. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
6. HLA-DQB1*0301 association with increased cutaneous melanoma risk.
Lee JE; Reveille JD; Ross MI; Platsoucas CD
Int J Cancer; 1994 Nov; 59(4):510-3. PubMed ID: 7960221
[TBL] [Abstract][Full Text] [Related]
7. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
8. Allele and haplotype frequencies at human leukocyte antigen class I and II genes in Venezuela's population.
Del Pilar Fortes M; Gill G; Paredes ME; Gamez LE; Palacios M; Blanca I; Tassinari P
Ann Biol Clin (Paris); 2012; 70(2):175-81. PubMed ID: 22484528
[TBL] [Abstract][Full Text] [Related]
9. The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression.
Kandilarova SM; Paschen A; Mihaylova A; Ivanova M; Schadendorf D; Naumova E
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):73-81. PubMed ID: 28083606
[TBL] [Abstract][Full Text] [Related]
10. HLA-DRB1
Wang X; Almazan F; Montoyo-Pujol YG; Martin-Casares A; Martin A; Cabrera T; López-Nevot MA
J Oncol; 2021; 2021():3801143. PubMed ID: 34630564
[TBL] [Abstract][Full Text] [Related]
11. Allele and haplotype frequencies of HLA-A, B, C, DRB1 and DQB1 genes in polytransfused patients in ethnically diverse populations from Brazil.
Rodrigues C; Macedo LC; Bruder AV; Quintero Fd; de Alencar JB; Sell AM; Visentainer JE
Int J Immunogenet; 2015 Oct; 42(5):322-8. PubMed ID: 26223649
[TBL] [Abstract][Full Text] [Related]
12. DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain.
Fernández O; Fernández V; Alonso A; Caballero A; Luque G; Bravo M; León A; Mayorga C; Leyva L; de Ramón E
J Neurol; 2004 Apr; 251(4):440-4. PubMed ID: 15083289
[TBL] [Abstract][Full Text] [Related]
13. MHC class I chain-related gene a diversity in patients with cutaneous malignant melanoma from southeastern Spain.
Campillo JA; López-Hernández R; Martínez-Banaclocha H; Bolarín JM; Gimeno L; Mrowiec A; López M; Las Heras B; Minguela A; Moya-Quiles MR; Legáz I; Frías-Iniesta JF; García-Alonso AM; Álvarez-López MR; Martínez-Escribano JA; Muro M
Dis Markers; 2015; 2015():831864. PubMed ID: 25838620
[TBL] [Abstract][Full Text] [Related]
14. HLA-DQB1*0303 and *0301 alleles influence susceptibility to and prognosis in cutaneous malignant melanoma in the British Caucasian population.
Bateman AC; Turner SJ; Theaker JM; Howell WM
Tissue Antigens; 1998 Jul; 52(1):67-73. PubMed ID: 9714476
[TBL] [Abstract][Full Text] [Related]
15. Susceptible and Protective Associations of HLA Alleles and Haplotypes with Cervical Cancer in South India.
Rathika C; Murali V; Dhivakar M; Kamaraj R; Malini RP; Ramgopal S; Balakrishnan K
Asian Pac J Cancer Prev; 2016; 17(5):2491-7. PubMed ID: 27268619
[TBL] [Abstract][Full Text] [Related]
16. Malignant melanoma: relationship of the human leukocyte antigen class II gene DQB1*0301 to disease recurrence in American Joint Committee on Cancer Stage I or II.
Lee JE; Lu M; Mansfield PF; Platsoucas CD; Reveille JD; Ross MI
Cancer; 1996 Aug; 78(4):758-63. PubMed ID: 8756369
[TBL] [Abstract][Full Text] [Related]
17. Loss of single HLA class I allospecificities in melanoma cells due to selective genomic abbreviations.
Geertsen R; Böni R; Blasczyk R; Romero P; Betts D; Rimoldi D; Hong X; Laine E; Willers J; Dummer R
Int J Cancer; 2002 May; 99(1):82-7. PubMed ID: 11948496
[TBL] [Abstract][Full Text] [Related]
18. HLA class-I and HLA class-II phenotypic, gene and haplotypic frequencies in Tunisians by using molecular typing data.
Ayed K; Ayed-Jendoubi S; Sfar I; Labonne MP; Gebuhrer L
Tissue Antigens; 2004 Oct; 64(4):520-32. PubMed ID: 15361135
[TBL] [Abstract][Full Text] [Related]
19. Human leukocyte antigen Class II alleles associated with acral lentiginous melanoma in Mexican Mestizo patients: A case-control study.
Roldan-Marin R; Rangel-Gamboa L; Vega-Memije ME; Hernández-Doño S; Ruiz-Gómez D; Granados J
Indian J Dermatol Venereol Leprol; 2022; 88(5):608-614. PubMed ID: 35138055
[TBL] [Abstract][Full Text] [Related]
20. Association of HLA alleles with hepatitis C infection in Maharashtra, western India.
Tripathy AS; Shankarkumar U; Chadha MS; Ghosh K; Arankalle VA
Indian J Med Res; 2009 Nov; 130(5):550-5. PubMed ID: 20090103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
